IGF1 and cancer: Being synthesized by cells such as premature or mature osteoblasts, osteocytes, and osteoclasts, IGF-1 binds to cell surface receptors to stimulate the proliferation and differentiation of osteoblast precursors, thereby enhancing bone formation and maintaining bone mass and creating a bone microenvironment that caters to cancer cell growth (Figure 1) [78,79].